Rheumatoid arthritis.
Why self-perpetuating joint destruction is intermittent in some patients and unrelenting in others remains largely unknown, but progress has been made in identifying the different types of clinical course and tailoring specific treatment regimens for each.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D001241:Aspirin / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D007595:Joint Prosthesis; D008214:Lymphocytes / Q000502:physiology; D010396:Penicillamine / Q000627:therapeutic use; D010956:Plasmapheresis; D011720:Pyrazoles / Q000627:therapeutic use; D000074402:Synovectomy
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D011720:Pyrazoles; D006046:Gold; D010396:Penicillamine; D001241:Aspirin; D007213:Indomethacin